Tanke Biosciences Corporation
TNBI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $764 | $3,165 | $1,261 | $15,550 |
| - Cash | $0 | $3 | $7 | $41 |
| + Debt | $140 | $140 | $53 | $2 |
| Enterprise Value | $904 | $3,302 | $1,307 | $15,511 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$9 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$116 | -$18 | $30 | -$55 |
| % Margin | – | – | – | – |
| Net Income | -$120 | -$83 | -$98 | -$723 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.005 | -0.004 | -0.008 | -0.057 |
| % Growth | -20.5% | 50.6% | 86.1% | – |
| Operating Cash Flow | -$35 | -$75 | -$59 | -$4 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$35 | -$75 | -$59 | -$4 |